NCT02985281View on ClinicalTrials.gov

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

September 30, 2017

Conditions
Pharmacological Action
Interventions
DRUG

Sofosbuvir Oral Product

direct acting antiviral drug for HCV infection

DRUG

Ribavirin

antiviral drug for HCV infection

Trial Locations (1)

32714

National liver institute, Sijīn al Kawm

Sponsors

Collaborators (1)

Pharco Pharmaceuticals
All Listed Sponsors
collaborator

Pharco Pharmaceuticals

INDUSTRY

lead

National Liver Institute, Egypt

OTHER